Novomer funnels carbon dioxide into plastics, nabs $14M
Novomer, a polymer company with disruptive potential, has made catalysts capable of transforming carbon dioxide and carbon monoxide into plastics and marketable chemicals — and now it’s raised $14 million in a second round of venture funding to scale its technology. Based in Boston, Mass., the company, which relies on an extensive patent estate, is one of a very small handful of firms racing to create biodegradable plastics.
Turning carbon gases into feedstock for profitable chemical… Continue Reading
LIfe sciences briefing: Tuesday, Jan. 15, 2007
TODAY’S HEADLINES:
Pervasis Thera pulls in $9.8M for regenerative medicine (release)
Embrella Cardio receives $2.3M for stroke-prevention heart-surgery devices (release)
Vivendy Thera raises CHF 17M for rare-disease drug (Private Equity Europe)
Novacta Bio gets £3.5M grant for anti-infective drugs (release)
Metavante acquires health-plan admin software co. Bensoft (release)
Pharma-marketing analyst ImpactRx acquires Paragon Research (release)
Arteriocyte gets $509K grant for stem-cell work (release)
HBM BioVentures shoots for Swiss IPO (Reuters)
Covington Capital assumes control of NGB biotech fund (release)
Pervasis Thera pulls in $9.8M for… Continue Reading